Current Value
$19.051 Year Return
Current Value
$19.051 Year Return
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
PCRX | -34.64% | $1.08B | +2.24% | 0.00% |
AVD | -27.34% | $138.66M | -52.22% | 0.00% |
MITK | -21.05% | $463.84M | -8.86% | 0.00% |
CLX | -18.54% | $15.23B | -7.50% | 3.92% |
PINC | -17.82% | $1.79B | +17.43% | 3.92% |
EL | -14.97% | $30.62B | -19.61% | 2.00% |
SPTN | -12.47% | $897.01M | +45.29% | 3.30% |
MRK | -12.13% | $205.43B | -35.95% | 3.89% |
FIVN | -11.75% | $2.03B | -38.30% | 0.00% |
WBTN | -11.72% | $1.21B | -53.76% | 0.00% |
PUBM | -11.70% | $604.73M | -39.04% | 0.00% |
SAVA | -11.17% | $89.37M | -84.31% | 0.00% |
PYPL | -11.10% | $73.22B | +27.68% | 0.00% |
NFE | -10.66% | $995.27M | -81.83% | 0.00% |
MOH | -10.56% | $16.60B | +4.89% | 0.00% |
ATKR | -10.37% | $2.48B | -43.75% | 1.73% |
KVUE | -9.44% | $40.26B | +14.97% | 3.90% |
AQN | -9.29% | $4.56B | -2.54% | 4.53% |
CNXN | -8.81% | $1.69B | +3.95% | 0.75% |
NATR | -8.64% | $274.18M | -1.13% | 0.00% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
XGN | 33.95% | $152.81M | +292.70% | 0.00% |
TBRG | 32.34% | $352.75M | +121.93% | 0.00% |
PLTR | 30.63% | $308.39B | +405.92% | 0.00% |
CARG | 30.56% | $3.34B | +32.37% | 0.00% |
MKL | 28.66% | $25.30B | +26.31% | 0.00% |
APPS | 28.57% | $623.71M | +247.02% | 0.00% |
ADMA | 28.22% | $4.27B | +56.84% | 0.00% |
HONE | 26.05% | $516.04M | +8.22% | 2.75% |
IOVA | 25.90% | $581.05M | -77.49% | 0.00% |
RNA | 25.80% | $3.43B | -26.65% | 0.00% |
FLXS | 25.68% | $197.01M | +26.17% | 1.88% |
AKAM | 25.29% | $11.64B | -12.34% | 0.00% |
G | 25.12% | $7.86B | +41.42% | 1.44% |
AUDC | 25.03% | $285.52M | -7.32% | 3.72% |
TBCH | 24.97% | $290.11M | +2.27% | 0.00% |
DOCS | 24.55% | $10.97B | +116.54% | 0.00% |
DOCN | 24.52% | $2.55B | -20.33% | 0.00% |
VNET | 24.42% | $1.74B | +203.21% | 0.00% |
IAG | 24.32% | $4.19B | +97.83% | 0.00% |
SPOT | 24.21% | $145.13B | +128.92% | 0.00% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
VIXY | -21.39% | $165.58M | 0.85% |
TAIL | -16.93% | $99.49M | 0.59% |
BTAL | -11.02% | $295.67M | 1.43% |
USDU | -10.94% | $163.19M | 0.5% |
IVOL | -10.64% | $348.25M | 1.02% |
BILS | -9.66% | $3.83B | 0.1356% |
SPTS | -8.92% | $5.77B | 0.03% |
XHLF | -8.87% | $1.73B | 0.03% |
CARY | -8.85% | $347.36M | 0.8% |
XONE | -8.28% | $585.85M | 0.03% |
KMLM | -8.23% | $187.66M | 0.9% |
FTSM | -7.98% | $6.39B | 0.45% |
IBTG | -7.87% | $1.92B | 0.07% |
UUP | -7.80% | $209.45M | 0.77% |
VGSH | -7.68% | $22.77B | 0.03% |
SCHO | -7.43% | $11.46B | 0.03% |
FMF | -7.37% | $157.12M | 0.95% |
LDUR | -7.27% | $929.45M | 0.5% |
UTWO | -7.12% | $379.27M | 0.15% |
PSQA | -7.07% | $35.43M | 0.2% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
FRDM | 22.55% | $1.19B | 0.49% |
EMXC | 22.12% | $13.62B | 0.25% |
GWX | 21.99% | $703.55M | 0.4% |
CGBL | 21.95% | $2.53B | 0.33% |
IZRL | 21.81% | $114.42M | 0.49% |
EWD | 21.69% | $379.86M | 0.54% |
XCEM | 21.56% | $1.16B | 0.16% |
PXF | 21.56% | $2.03B | 0.43% |
PRNT | 21.54% | $77.58M | 0.66% |
ESGE | 21.47% | $5.02B | 0.26% |
CWI | 21.44% | $1.88B | 0.3% |
AVEM | 21.44% | $10.76B | 0.33% |
SPEU | 21.41% | $691.63M | 0.07% |
FXC | 21.37% | $93.05M | 0.4% |
ILF | 21.37% | $1.63B | 0.48% |
FYLD | 21.32% | $396.03M | 0.59% |
EEM | 21.27% | $18.34B | 0.72% |
IEMG | 21.26% | $95.51B | 0.09% |
ACWX | 21.22% | $6.43B | 0.32% |
BBCA | 21.20% | $8.28B | 0.19% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
LMBS | 0.01% | $5.10B | 0.64% |
SHM | 0.07% | $3.41B | 0.2% |
SUSB | 0.11% | $987.13M | 0.12% |
OWNS | -0.16% | $130.26M | 0.3% |
UNG | -0.18% | $388.31M | 1.06% |
IBTP | -0.23% | $143.32M | 0.07% |
NUBD | 0.24% | $396.52M | 0.16% |
FLGV | -0.24% | $1.01B | 0.09% |
TOTL | -0.27% | $3.86B | 0.55% |
BOND | 0.28% | $5.65B | 0.7% |
IBMS | 0.29% | $88.27M | 0.18% |
DFIP | -0.30% | $920.81M | 0.11% |
JPST | -0.31% | $31.88B | 0.18% |
GSY | -0.37% | $2.86B | 0.22% |
IBTO | -0.39% | $351.41M | 0.07% |
TESL | 0.39% | $32.75M | 1.2% |
FIXD | 0.45% | $3.41B | 0.65% |
VNLA | -0.45% | $2.62B | 0.23% |
VMBS | 0.47% | $14.44B | 0.03% |
MMIN | 0.47% | $335.49M | 0.3% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
KNX | -0.01% | $7.47B | -7.39% | 1.48% |
CYD | 0.04% | $876.80M | +155.41% | 3.92% |
IHRT | 0.05% | $274.58M | +56.30% | 0.00% |
PRGO | 0.06% | $3.77B | +5.54% | 4.10% |
ALLO | 0.06% | $258.10M | -45.37% | 0.00% |
PTCT | -0.06% | $3.85B | +59.89% | 0.00% |
APPF | 0.07% | $8.28B | -7.02% | 0.00% |
MCD | -0.08% | $212.72B | +20.06% | 2.36% |
NKE | -0.09% | $108.35B | -3.46% | 2.11% |
SVV | -0.10% | $1.66B | -14.45% | 0.00% |
COLM | 0.10% | $3.47B | -17.88% | 1.89% |
DLX | 0.11% | $729.71M | -26.10% | 7.31% |
PARAA | -0.11% | $15.30B | +17.49% | 0.88% |
ANGO | 0.11% | $386.58M | +68.20% | 0.00% |
IP | 0.12% | $26.10B | +13.68% | 3.74% |
GRAL | -0.12% | $1.77B | +227.11% | 0.00% |
WOLF | 0.13% | $62.06M | -98.23% | 0.00% |
CXW | 0.13% | $2.30B | +55.31% | 0.00% |
MNOV | 0.14% | $62.29M | -9.29% | 0.00% |
AWR | -0.15% | $3.00B | +7.57% | 2.40% |
Yahoo
TORONTO, June 27, 2025 (GLOBE NEWSWIRE) -- Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) (FRA: 0K91) ("Quantum BioPharma" or the "Company"), a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions, is pleased to announce that it is completing a non-brokered private placement of class A multiple voting shares (“MVS”) at a price of $50 per MVS, for aggregate gross proceeds of up to $600 (the “Offering”). The Company expects that the entirety of
Yahoo
TORONTO, June 27, 2025 (GLOBE NEWSWIRE) -- Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) (FRA: 0K91) ("Quantum BioPharma" or the "Company"), a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions, is pleased to announce that it is completing a non-brokered private placement of class A multiple voting shares (“MVS”) at a price of $50 per MVS, for aggregate gross proceeds of up to $600 (the “Offering”). The Company expects that the entirety of
Yahoo
Engages leading marketing firm MZ Digital and crowdfunding platform Dealmaker to successfully execute raiseTORONTO, June 26, 2025 (GLOBE NEWSWIRE) -- Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) (FRA: 0K91) (“Quantum BioPharma”), a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions, announces that Unbuzzd Wellness Inc. (the "Company" or "Unbuzzd"), the company behind unbuzzd™—the scientifically-proven and game-changing beverage that accele
Yahoo
Los Angeles, California--(Newsfile Corp. - June 18, 2025) - Singular Research, a leading provider of independent research on small-cap companies, today released its analysis of Quantum BioPharma Ltd.'s (NASDAQ: QNTM) continued progress across its innovative pipeline of treatments for brain disorders and alcohol health.A link to the report is available here: https://files.constantcontact.com/1683279a601/2551ab59-a629-4103-8f4b-fa3fbf21f4a5.pdf?rdr=trueClinical Development MilestonesQuantum BioPha
Yahoo
Joint Clinical Study with Massachusetts General Hospital Could Pave the Way for Testing Efficacy of Quantum’s Investigational MS drug, Lucid-21-302TORONTO, June 17, 2025 (GLOBE NEWSWIRE) -- Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) (FRA: 0K91) (“Quantum BioPharma” or the “Company”), a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions, announces that the first person with multiple sclerosis (MS) has been scanned in a joint study with Ma
Yahoo
TORONTO, June 13, 2025 (GLOBE NEWSWIRE) -- Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) (FRA: 0K91) (“Quantum BioPharma” or the “Company”), a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions, is pleased to announce its intention to declare a special dividend consisting of Contingent Value Rights (the “CVRs”) to be issued on a 1:1 basis to holders of the Company’s Class B Subordinate Voting Shares. Each CVR will entitle the holder to rece